Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | BCL9 | O00512 | 1/20 | 0.42 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | HTR1B | P28222 | 1/20 | 0.40 |
| ▸ | RET | P07949 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22334843 | 0.95 | KMT2A (0.47) | KMT2ASMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL22334784 | 0.91 | KMT2A (0.51) | KMT2ASMN1; SMN2ALDH1A1LMNAMAPT | |
| SCHEMBL22337058 | 0.89 | BCL9 (0.53) | KMT2ASMN1; SMN2RAB9AALDH1A1LMNA | |
| SCHEMBL22334763 | 0.88 | KMT2A (0.56) | KMT2ASMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL27652865 | 0.86 | KMT2A (0.55) | KMT2ASMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL15987811 | 0.85 | KMT2A (0.57) | KMT2ASMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL9016841 | 0.85 | KMT2A (0.57) | KMT2ASMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL32685014 | 0.85 | KMT2A (0.57) | KMT2ASMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL32684888 | 0.85 | KMT2A (0.57) | KMT2ASMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL31094048 | 0.85 | KMT2A (0.57) | KMT2ASMN1; SMN2NPC1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4039220-B1 | DENTAL MATERIALS ON THE BASIS OF POLYMERISABLE THIOUREA DERIVATIVES | IVOCLAR VIVADENT AG (LI) | 2022-12-28 | — | — | EP | disclosed |
| US-11357709-B2 | Dental materials based on redox systems with low-odour cumene hydroperoxide derivatives | IVOCLAR VIVADENT AG (LI) | 2022-06-14 | — | — | US | disclosed |
| EP-3692976-B1 | DENTAL MATERIALS BASED ON REDOX SYSTEMS WITH LOW ODOR CUMENE HYDROPEROXIDE DERIVATIVES | IVOCLAR VIVADENT AG (LI) | 2021-03-31 | — | — | EP | disclosed |
| US-20200253837-A1 | Dental Materials Based On Redox Systems With Low-Odour Cumene Hydroperoxide Derivatives | IVOCLAR VIVADENT AG (LI) | 2020-08-13 | — | — | US | disclosed |
| EP-3692976-A1 | DENTAL MATERIALS BASED ON REDOX SYSTEMS WITH LOW ODOR CUMOLHYDE-HYDROPEROXIDE DERIVATIVES | Ivoclar Vivadent AG (LI) | 2020-08-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11357709-B2 | Dental materials based on redox systems with low-odour cumene hydroperoxide derivatives | GPX4, GPX1, AOX1 | KMT2A 3656/4885SMN1; SMN2 3942/4885NPC1 4553/4885 |
| US-20200253837-A1 | Dental Materials Based On Redox Systems With Low-Odour Cumene Hydroperoxide Derivatives | GPX4, GPX1, AOX1 | KMT2A 3656/4885SMN1; SMN2 3942/4885NPC1 4553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.